Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
Eli Lilly (LLY.US) to Acquire Sleep Drug Maker Centessa (CNTA.US) for Up to USD7.8 Billion; Centessa's Stock Surges 46% Pre-Market
Recommend 4 Positive 3 Negative 1 |
||||
|
||||
|
Eli Lilly (LLY.US) announced on Tuesday that it has agreed to acquire sleep medication manufacturer Centessa Pharmaceuticals (CNTA.US) for up to USD7.8 billion to expand its product portfolio. Centessa's stock surged approximately 46% pre-market. Centessa is developing drugs for the treatment of sleep-wake disorders, including narcolepsy. The company stated it will acquire Centessa at a price of USD38 per share, with an additional payment of USD9 per share contingent upon achieving three milestone targets. (sw/t) This article was automatically translated by AI, the Chinese version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation. Auto-translated by AI AASTOCKS Financial News |
||||
Copied to Clipboard
 |
||||
